Nuvation Bio Inc. Class A Common Stock vs TTM Technologies Inc. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while TTM Technologies Inc. Common Stock trades at $120.59 (market cap $13.51B). The key difference: TTM Technologies Inc. Common Stock is far larger — about 7.9× Nuvation Bio Inc. Class A Common Stock's market cap, and TTM Technologies Inc. Common Stock is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and TTM Technologies Inc. Common Stock for 0 Days on average.
| NUVB | TTMI | |
|---|---|---|
Market Cap | $1.71B | $13.51B |
Volume | 5,448,712 | 1,755,886 |
Sector | Health | Technology |
52-Week High | $9.54 | $221.47 |
52-Week Low | $3.41 | $53.58 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $14.11B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →TTM Technologies manufactures printed circuit boards, radio-frequency components, and electronics assemblies. Its products are used in aerospace, defense, automotive, data center, and communications equipment.
Read more on TTMI →